Comparing the Two Top Stocks: Sage Therapeutics, Inc. (NASDAQ:SAGE), United Technologies Corporation (NYSE:UTX)

u.s stocks , earnings estimates

Sage Therapeutics, Inc. (NASDAQ:SAGE)

Sage Therapeutics, Inc. (NASDAQ:SAGE) closed at $172.48 on the last trading session with an increase of 2.5%, whereas, it previously closed at $168.27. The company has a market capitalization of $8.91 Billion. The company traded shares of 442348 on the trading day while its three month average volume stands at 392.18 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) produced diluted EPS of -9.74. The EPS estimate for next year as estimated by analysts is at -12.18 while EPS for next quarter is estimated at -3.33. Earnings per Share growth for this year is reported at -14.1, while the analysts estimated the EPS growth for next year at -12.18% and Earnings growth for next 5 years stands at 13.1% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -60.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Sage Therapeutics, Inc. (NASDAQ:SAGE) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Sage Therapeutics, Inc. (NASDAQ:SAGE) stands at 98.26 and Price to Book or P/B for the most recent quarter stands at 6.34. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Sage Therapeutics, Inc. (NASDAQ:SAGE) are reported at 20.1 and 20.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Sage Therapeutics, Inc. (NASDAQ:SAGE) stands at -40.6, -43.5 and -45.6 respectively

The trailing twelve month Revenue of Sage Therapeutics, Inc. (NASDAQ:SAGE) is reported at 90.7 Million with income of -461700000. The outstanding shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) are 51.67 Million. The institutional Ownership of the shares of 98.75 stands at 0.80%, this figure is increased 6.84 in the last six months. The insider ownership for the shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) is ticked at 1.4%, the figure is plummeted -34.13% in the last six months.

Some other important financial aspects to be discussed here for Sage Therapeutics, Inc. (NASDAQ:SAGE) is the Mean Target Price estimated by the analysts which stands at 203. The 52 week high of Sage Therapeutics, Inc. (NASDAQ:SAGE) is placed at 193.56 and 52 week low is standing at 79.88.

Performance wise the shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) rose up 6.2% for the week, it also fell -8.03% for the monthly performance, while for the quarter it went down 1.32%. The shares increase 17.57% for the half year and flew up for the Year-To-Date performance. The shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) grew 16.86% for the yearly performance.

United Technologies Corporation (NYSE:UTX)

United Technologies Corporation (NYSE:UTX) closed at $131.48 on the last trading session with an increase of 1.91%, whereas, it previously closed at $129.01. The company has a market capitalization of $114.34 Billion. The company traded shares of 2.68 Million on the trading day while its three month average volume stands at 3.58 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of United Technologies Corporation (NYSE:UTX) produced diluted EPS of 6.96. The EPS estimate for next year as estimated by analysts is at 8.8 while EPS for next quarter is estimated at 2.02. Earnings per Share growth for this year is reported at 13.2, while the analysts estimated the EPS growth for next year at 8.8% and Earnings growth for next 5 years stands at 8.65% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 5.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of United Technologies Corporation (NYSE:UTX) is at 18.89 while the forward p/e is at 14.95. The P/S or Price to Sales ratio of United Technologies Corporation (NYSE:UTX) stands at 1.58 and Price to Book or P/B for the most recent quarter stands at 2.76. The Price to Free Cash Flow ratio or P/FCF is reported at 37.66. The quick ratio and the current ratio of United Technologies Corporation (NYSE:UTX) are reported at 0.7 and 1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for United Technologies Corporation (NYSE:UTX) stands at 3.9, 13.7 and 7.9 respectively

The trailing twelve month Revenue of United Technologies Corporation (NYSE:UTX) is reported at 72.55 Billion with income of 5.87 Billion. The outstanding shares of United Technologies Corporation (NYSE:UTX) are 869.63 Million. The institutional Ownership of the shares of 83.4 stands at 0.80%, this figure is increased 0.41 in the last six months. The insider ownership for the shares of United Technologies Corporation (NYSE:UTX) is ticked at 0.1%, the figure is plummeted -5.35% in the last six months.

Some other important financial aspects to be discussed here for United Technologies Corporation (NYSE:UTX) is the Mean Target Price estimated by the analysts which stands at 152.44. The 52 week high of United Technologies Corporation (NYSE:UTX) is placed at 144.40 and 52 week low is standing at 100.48.

Performance wise the shares of United Technologies Corporation (NYSE:UTX) fell down -0.27% for the week, it also rise 0.79% for the monthly performance, while for the quarter it went up -3.93%. The shares increase 8.91% for the half year and flew up for the Year-To-Date performance. The shares of United Technologies Corporation (NYSE:UTX) shrinked -2.24% for the yearly performance.